Journal of Internal Medicine Concepts & Practice >

2021 , Vol. 16 >Issue 03: 188 - 192

DOI: https://doi.org/10.16138/j.1673-6087.2021.03.010

Original article

Risk factors of asymptomatic erosive esophagitis

Expand
  • Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2020-12-23

  Online published: 2022-07-26

Fold

Abstract

Objective To explore the prevalence, risk factors, prognosis, and management of asymptomatic erosive esophagitis(AEE). Methods A total of 5 184 asymptomatic individuals who underwent gastroscopy for routine health checkup were included in our study. 475 (9.2%) patients with EE devoid of gastroesophageal reflux disease(GERD) symptoms were selected as AEE group. A total of 950 age- and gender-matched subjects with negative endoscopic findings were selected as healthy control group. The clinical data between the two groups were compared. The independent risk factors, prognosis, and treatment of AEE were analyzed. Results A higher body mass index (BMI) [odds ratio（OR）=1.101, P=0.001], fatty liver（OR=1.635, P=0.013）, hiatus hernia（OR=2.302, P=0.039）, and higher gamma-glutamyl transferase (GGT)(OR=1.008, P=0.013) were independent risk factors for AEE. A total of 140 patients were followed up after they were diagnosed with AEE. Regardless of treatment, improved esophagitis occurred in about 2/3 AEE patients（82.4% vs 65.3%）. However, the proportion of subjects with improved esophagitis was much higher in the proton pump inhibitor(PPI) treatment group than that in the non-treatment group. Conclusions Higher BMI, fatty liver, hiatus hernia, and higher GGT are independent risk factors for AEE. The prognosis of AEE is good and PPI treatment could improve AEE.

Key words： Gastroesophageal reflux disease; Hiatus hernia; Gastroscopy; Proton pump inhibitor

Cite this article

SUN Chao, YAO Weiyan, HUANG Jia, ZHU Ying, TANG Yuming . Risk factors of asymptomatic erosive esophagitis[J]. Journal of Internal Medicine Concepts & Practice, 2021 , 16(03) : 188 -192 . DOI: 10.16138/j.1673-6087.2021.03.010

References

[1] Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus[J]. Am J Gastroenterol, 2006, 101(8): 1900-1920.
[2] Nozu T, Komiyama H. Clinical characteristics of asymptomatic esophagitis[J]. J Gastroenterol, 2008, 43(1): 27-31.
[3] Wang PC, Hsu CS, Tseng TC, et al. Male sex, hiatus hernia, and Helicobacter pylori infection associated with asymptomatic erosive esophagitis[J]. J Gastroenterol Hepatol, 2012, 27(3): 586-591.
[4] Ronkainen J, Talley NJ, Storskrubb T, et al. Erosive esophagitis is a risk factor for Barrett’s esophagus: a community-based endoscopic follow-up study[J]. Am J Gastroenterol, 2011, 106(11): 1946-1952.
[5] Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification[J]. Gut, 1999, 45(2): 172-180.
[6] Lee CL, Liu CC, Liao CC, et al. Reuse of CLO test in the diagnosis of Helicobacter pylori infection[J]. J Formos Med Assoc, 2002, 101(4): 298-300.
[7] Ferwana M, Abdulmajeed I, Alhajiahmed A, et al. Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis[J]. World J Gastroenterol, 2015, 21(4): 1305-1314.
[8] 中华医学会消化病学分会. 2014年中国胃食管反流病专家共识意见[J]. 中华消化杂志, 2014, 34(10): 649-661.
[9] Lee SP, Sung IK, Kim JH, et al. The clinical features and predisposing factors of asymptomatic erosive esophagitis[J]. Dig Dis Sci, 2016, 61(12): 3522-3529.
[10] Lei WY, Yu HC, Wen SH, et al. Predictive factors of silent reflux in subjects with erosive esophagitis[J]. Dig Liver Dis, 2015, 47(1): 24-29.
[11] Peng S, Cui Y, Xiao YL, et al. Prevalence of erosive esophagitis and Barrett’s esophagus in the adult Chinese population[J]. Endoscopy, 2009, 41(12): 1011-1017.
[12] Cho JH, Kim HM, Ko GJ, et al. Old age and male sex are associated with increased risk of asymptomatic erosive esophagitis: analysis of data from local health examinations by the Korean National Health Insurance Corporation[J]. J Gastroenterol Hepatol, 2011, 26(6): 1034-1038.
[13] Lee D, Lee KJ, Kim KM, et al. Prevalence of asymptomatic erosive esophagitis and factors associated with symptom presentation of erosive esophagitis[J]. Scand J Gastroenterol, 2013, 48(8): 906-912.
[14] Wang FW, Tu MS, Chuang HY, et al. Erosive esophagitis in asymptomatic subjects: risk factors[J]. Dig Dis Sci, 2010, 55(5): 1320-1324.
[15] Singh S, Sharma AN, Murad MH, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2013, 11(11): 1399-1412.
[16] Loke SS, Yang KD, Chen KD, et al. Erosive esophagitis associated with metabolic syndrome, impaired liver function, and dyslipidemia[J]. World J Gastroenterol, 2013, 19(35): 5883-5888.
[17] Gunji T, Sato H, Iijima K, et al. Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males[J]. J Gastroenterol, 2011, 46(4): 448-455.
[18] Lee SW, Lien HC, Chang CS, et al. Association of metabolic syndrome with erosive esophagitis and Barrett’s esophagus in a Chinese population[J]. J Chin Med Assoc, 2017, 80(1): 15-18.
[19] Kim TJ, Lee H, Baek SY, et al. Metabolically healthy obesity and the risk of erosive esophagitis: a cohort study[J]. Clin Transl Gastroenterol, 2019, 10(9): e00077.
[20] Park JH, Park DI, Kim HJ, et al. Metabolic syndrome is associated with erosive esophagitis[J]. World J Gastroenterol, 2008, 14(35): 5442-5447.
[21] Tai CM, Lee YC, Tu HP, et al. The relationship between visceral adiposity and the risk of erosive esophagitis in severely obese Chinese patients[J]. Obesity (Silver Spring), 2010, 18(11): 2165-2169.
[22] Yucel O. Interactions between Helicobacter pylori and gastroesophageal reflux disease[J]. Esophagus, 2019, 16(1): 52-62.
[23] Xie T, Cui X, Zheng H, et al. Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease[J]. Eur J Gastroenterol Hepatol, 2013, 25(10): 1195-1205.
[24] Corley DA, Kubo A, Levin TR, et al. Helicobacter pylori and gastroesophageal reflux disease: a case-control study[J]. Helicobacter, 2008, 13(5): 352-360.
[25] Lai EJ, Calderwood AH, Doros G, et al. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research[J]. Gastrointest Endosc, 2009, 69(3 Pt 2): 620-625.
[26] Min YW, Kim Y, Gwak GY, et al. Non-alcoholic fatty liver disease and the development of reflux esophagitis: a cohort study[J]. J Gastroenterol Hepatol, 2018, 33(5): 1053-1058.
[27] Choi JS, Kim HM, Yang YJ, et al. Fatty liver disease and the risk of erosive oesophagitis in the Korean population: a cross-sectional study[J]. BMJ Open, 2019, 9(1): e023585.
[28] Jung SH, Oh JH, Kang SG. Clinical characteristics and natural history of asymptomatic erosive esophagitis[J]. Turk J Gastroenterol, 2014, 25(3): 248-252.
Options
Outlines

/

〈 〉